Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 62 | 1 | 6 | 1 | €729.50 | €824.47 | 13.018% |
| Vertex Pharmaceuticals Inc. | 57 | 2 | 5 | 0 | €453.55 | €440.93 | -2.783% |
| Biogen Inc. | 52 | 2 | 5 | 1 | €187.65 | €289.80 | 54.436% |
| Alnylam Pharmace. | 48 | 0 | 4 | 0 | €247.40 | €270.83 | 9.471% |
| Regeneron Pharmaceuticals Inc. | 48 | 1 | 7 | 0 | €997.40 | €1,048.1 | 5.079% |
| Insmed Inc. | 42 | 0 | 7 | 0 | €68.50 | €71.14 | 3.854% |
| Johnson & Johnson | 41 | 1 | 5 | 0 | €149.50 | €179.00 | 19.732% |
| Neurocrine Bioscience | 39 | 0 | 8 | 0 | €139.60 | €149.47 | 7.072% |
| Cytokinetics Inc. | 34 | 1 | 0 | 0 | €51.50 | €83.92 | 62.944% |
| Merck & Co. Inc. | 33 | 1 | 4 | 0 | €105.60 | €125.72 | 19.052% |
| Intra-Cellular Therapies Inc. | 31 | 0 | 1 | 0 | €70.50 | €83.92 | 19.036% |
| AbbVie Inc. | 31 | 0 | 9 | 0 | €172.02 | €180.22 | 4.766% |
| Acadia Pharmaceuticals | 29 | 1 | 1 | 0 | €16.47 | €31.28 | 89.983% |
| Pfizer Inc. | 29 | 4 | 2 | 0 | €27.73 | €41.49 | 49.657% |
| Amgen Inc. | 25 | 0 | 1 | 0 | €303.20 | €304.65 | 0.477% |
| United Therapeutics | 25 | 1 | 4 | 1 | €295.30 | €290.24 | -1.714% |
| Ultragenyx Pharmaceutical Inc. | 24 | 1 | 3 | 0 | €41.20 | €92.48 | 124.459% |
| Zoetis Inc. A | 23 | 1 | 0 | 0 | €165.16 | €200.06 | 21.130% |
| Halozyme Therapeutics Inc. | 21 | 0 | 1 | 0 | €49.17 | €53.53 | 8.860% |
| Sutro Biopharma Inc | 21 | 0 | 0 | 0 | €3.60 | €11.04 | 206.733% |
| Ionis Pharmaceuticals Inc. | 27 | 6 | 7 | 1 | €45.34 | €56.58 | 24.793% |
| Natural Alternat. | 21 | 1 | 3 | 0 | €5.15 | - | - |
| Iovance Biotherapeutics Inc. | 22 | 2 | 0 | 0 | €7.17 | €26.25 | 265.955% |
| G1 Therapeutics | 21 | 1 | 0 | 0 | €3.65 | €10.54 | 189.019% |
| Exelixis Inc. | 20 | 0 | 3 | 0 | €22.05 | €26.01 | 17.943% |